Cingulate Inc. Note Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promissory Note, dated August 9, 2022, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
2022
Promissory Note issued to Streeterville Capital, LLC, dated December 20, 2024
Note Agreements
Cingulate Inc.
Pharmaceuticals
2024
Note Conversion Agreement, dated January 25, 2024, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC
Note Agreements
Cingulate Inc.
2024
Note Conversion Agreement, dated September 8, 2023, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC
Note Agreements
Cingulate Inc.
2023
Amended and Restated Promissory Note, dated May 9, 2023, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC
Note Agreements
Cingulate Inc.
2023
Amendment to Note, dated May 20, 2021, between Dresch Inc. and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
2021
Promissory Note, dated February 1, 2020, between Dresch Inc. and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Amendment to Note, dated April 19, 2021, between Raul Silva and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
2021
Promissory Note, dated July 25, 2020, between Raul Silva and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Amendment to Notes, dated April 28, 2021, between Matthew Brams and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
2021
Promissory Note, dated September 30, 2020, between Matthew Brams and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021
Promissory Note, dated February 26, 2020, between Matthew Brams and Cingulate Therapeutics, LLC
Note Agreements
Cingulate Inc.
Pharmaceuticals
DE
2021